Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO, Covance Drug Development
-
Stock Symbol
-
LH on NYSE
There are no Buy or Sell transactions made by Paul R. Kirchgraber since 4/23/2024
Holdings reported by Paul R. Kirchgraber for Labcorp Holdings Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
12.9K |
$2.84M |
$219.50 |
May 19, 2023 |
Direct |
|
|
| Restricted Stock Unit |
3K |
$632K |
$210.71 |
Feb 11, 2023 |
Direct |
Common Stock |
|
| Non-qualified Stock Options |
0 |
|
|
May 19, 2023 |
Direct |
Common Stock |
|
Transactions reported by Paul R. Kirchgraber for Labcorp Holdings Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.